Berkeley, CANCT07606625Now EnrollingIRB Ready

Dry Eye Clinical Trial in Berkeley, CA

Access cutting-edge dry eye treatment through this phase 4 clinical trial at a research site in Berkeley. Study-provided care at no cost to qualified participants.

Sponsored by University of California, Berkeley

Quick Self-Assessment

See if you qualify for this Berkeley location

Preparing your pre-screening questions…

Expert Care in Berkeley

Access dry eye specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related dry eye treatment provided free

Apply for This Berkeley Location

Check if you qualify for this dry eye clinical trial in Berkeley, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Berkeley

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Berkeley site if eligible
  4. 4Begin participation

About This Dry Eye Study in Berkeley

The purpose of this study is to examine the impact of nasal spray treatment on Meibomian gland function and ocular surface health in symptomatic dry eye patients with mild to moderate Meibomian gland dysfunction (MGD).

Sponsor: University of California, Berkeley

Who Can Participate

Inclusion Criteria

Is 18 years of age and has full legal capacity to volunteer (no max age requirement)
Baseline Ocular Surface Disease Index (OSDI) \>13
Has mild to moderate MGD
Has best corrected visual acuity of 20/40 or better
Has had an oculo-visual examination in the last two years
Is willing to continue other daily dry eye management regimen (e.g., warm compresses, and/or eyelid margin cleaning)
Is willing to discontinue other prescription medications for dry eye disease (DED) management
Is willing to stop any topical eye drops before all planned visits
Has read, understood, and completed the informed consent letter

Exclusion Criteria

Is participating in any other type of clinical or research study
Is currently pregnant, nursing, lactating, or planning a pregnancy
Is currently having \>50% blockage of Meibomian glands in more than two eyelids or significant atrophy (i.e., severe MGD)
Is currently using any topical ocular medications
Has chronic or currently active sinus related problems
Has blepharitis \> grade 1
Has active ocular infections
Has a condition or in a situation which, in the examiner's opinion, may put the subject at significant risk, may confound the study results, or may significantly interfere with their participation in the study
Has received Rx DED treatment within one week of enrollment
Has received any thermal or light-based DED treatment within 30 days of enrollment
Has significant corneal epithelial defects
Has abnormal eyelid anatomy
Has corneal neuropathic pain
Has chronic or recurrent epistaxis (nosebleeds), coagulation disorders, or other conditions that may have led to a clinically significant increased risk of bleeding
Has any intraocular surgery including trabeculectomy (MIGS, laser, or small incision glaucoma surgery allowed), extraocular surgery in either eye within 3 months, or refractive surgery within 12 months of enrollment
Has a known allergy to a product used in this study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Berkeley?

Yes, this clinical trial (NCT07606625) has an active research site in Berkeley, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Dry Eye Treatment Options in Berkeley, CA

If you're searching for dry eye treatment options in Berkeley, CA, this clinical trial (NCT07606625) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Berkeley research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced dry eye specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all dry eye clinical trials near you to find additional studies recruiting in your area.

More Sjogrens Syndrome Trials in Berkeley, CA

See all sjogrens syndrome clinical trials recruiting in Berkeley — not just this study.

Browse Sjogrens Syndrome Trials in Berkeley →

Browse More Trials by Condition

Sjogrens Syndrome TrialsDry Eye TrialsAll Conditions →

Ready to Join in Berkeley?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Berkeley, CA